Clarification sought from Neuland Laboratories

01 Mar 2017 Evaluate

The Exchange has sought clarification from Neuland Laboratories on March 01, 2017 with reference to news flashed on ET Now dated March 01, 2017, ‘US FDA grants priority review for SD-809’.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

13712.60 266.60 (1.98%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1389.35
Cipla 1506.15
Lupin 2228.00
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.